Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
reports
HLS Therapeutics Inc (HLS) Stock Price & Analysis
33 Followers
HLS Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$4.12 - C$13.89
Previous CloseC$4.26
Volume1.21K
Average Volume (3M)31.49K
Market Cap
C$139.11M
Enterprise ValueC$238.20M
Total Cash (Recent Filing)$21.21M
Total Debt (Recent Filing)$95.20M
Price to Earnings (P/E)-4.1
Beta1.20
Next Earnings
Aug 10, 2023EPS Estimate
-C$0.17Last Dividend Ex-Date
Apr 27, 2023Dividend Yield
0.15 (3.51%)Share Statistics
EPS (TTM)-1.05
Shares Outstanding32,523,233
10 Day Avg. Volume45,417
30 Day Avg. Volume31,493
Standard Deviation0.15
R-Squared0.09
Alpha-0.00727
Financial Highlights & Ratios
Price to Book (P/B)-2.05
Price to Sales (P/S)9.43
Price to Cash Flow (P/CF)8.70
P/FCF Ratio5.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.94
Enterprise Value/Gross Profit4.22
Enterprise Value/Ebitda30.86
Forecast
1Y Price Target
C$15.00Price Target Upside252.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
HLS FAQ
What was HLS Therapeutics Inc’s price range in the past 12 months?
HLS Therapeutics Inc lowest stock price was C$4.12 and its highest was C$13.89 in the past 12 months.
What is HLS Therapeutics Inc’s market cap?
Currently, no data Available
When is HLS Therapeutics Inc’s upcoming earnings report date?
HLS Therapeutics Inc’s upcoming earnings report date is Aug 10, 2023 which is in 64 days.
How were HLS Therapeutics Inc’s earnings last quarter?
HLS Therapeutics Inc released its earnings results on May 11, 2023. The company reported -C$0.242 earnings per share for the quarter, missing the consensus estimate of -C$0.159 by -C$0.083.
Is HLS Therapeutics Inc overvalued?
According to Wall Street analysts HLS Therapeutics Inc’s price is currently Undervalued.
Does HLS Therapeutics Inc pay dividends?
HLS Therapeutics Inc pays a Quarterly dividend of C$0.05 which represents an annual dividend yield of 4.65%. See more information on HLS Therapeutics Inc dividends here
What is HLS Therapeutics Inc’s EPS estimate?
HLS Therapeutics Inc’s EPS estimate is -C$0.17.
How many shares outstanding does HLS Therapeutics Inc have?
HLS Therapeutics Inc has 32,350,525 shares outstanding.
What happened to HLS Therapeutics Inc’s price movement after its last earnings report?
HLS Therapeutics Inc reported an EPS of -C$0.242 in its last earnings report, missing expectations of -C$0.159. Following the earnings report the stock price went down -10.87%.
Which hedge fund is a major shareholder of HLS Therapeutics Inc?
Currently, no hedge funds are holding shares in TSE:HLS
---
HLS Therapeutics Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$15.00 (252.11% Upside)
C$15.00 (252.11% Upside)
Insider Transactions
Bought Shares
Worth C$111.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.09%
12-Months-Change
Fundamentals
Return on Equity
-18.91%
Trailing 12-Months
Asset Growth
-6.22%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
HLS Therapeutics Inc
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada and the United States.
---
Top 5 ETFs holding HLS
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold HLS. The ETFs are listed according to market value of HLS within the ETF
---
---